MedPath

The Effect of Antenatal Corticosteroid on Umbilical Artery Doppler Velocimetry in IUGR

Completed
Conditions
Intrauterine Growth Restriction
Interventions
Other: ultrasonography
Registration Number
NCT05588986
Lead Sponsor
Merve Demir
Brief Summary

The purpose of this study is to evaluate the effect of antenatal corticosteroid administration on umbilical artery Doppler velocimetry measurements in pregnancies complicated by IUGR.

Detailed Description

This study was conducted with pregnant women who were likely to have preterm birth and were treated with antenatal corticosteroids. Betamethasone was used as an antenatal corticosteroid. UA Doppler measurements (PI, S/D ratio, RI) before antenatal corticosteroid administration and 24 and 48 hours after the last dose of corticosteroid administration were evaluated in pregnant groups complicated with IUGR and uncomplicated with IUGR and compared with each other.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
149
Inclusion Criteria

pregnant women who were likely to have preterm delivery and were treated with antenatal corticosteroids.

Exclusion Criteria

Pregnant women who had complicated pregnancy with fetal anomaly, who had multiple pregnancies, who left their pregnancy follow-up unfinished, and those under 18 years of age were excluded from the study.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
with IUGRultrasonographyPregnant women who received antenatal corticosteroid therapy and complicated with intrauterine growth retardation
without IUGRultrasonographyPregnant women who received antenatal corticosteroid therapy and were not complicated by intrauterine growth retardation
Primary Outcome Measures
NameTimeMethod
Resistive Index (RI)2018-2019

Resistive Index (RI) = (Peak systolic velocity - end diastolic velocity)/(peak systolic velocity)

pulsatility index (PI)2018-2019

Pulsatility Index (PI) = (Peak systolic velocity - end diastolic velocity)/(time averaged maximum velocity)

systolic:diastolic ratio (S/D ratio)2018-2019

Peak systolic velocity/end diastolic velocity

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Merve Demir

🇹🇷

Kocaeli, Turkey

© Copyright 2025. All Rights Reserved by MedPath